Dr Reddy's executive says we will be on track to supply between 6-7mln of Novo Nordisk's (NOVOB DC) Semaglutide pens between Q3 and Q4
- Issue is nothing to do with whatever we sent to market.
- Actual supply to market can resume in late October to early November if issue resolved.
- There will be halt of supply between now and September.
- We got to know about the issue on Wednesday
#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#EUROPEAN EQUITIES